Zobrazeno 1 - 10
of 598
pro vyhledávání: '"Yuji, Taketani"'
Autor:
Rena Toriumi, Michiharu Horikawa, Chie Sato, Nagisa Shimamura, Rena Ishii, Michiru Terashima, Michiko Hamada, Naoyuki Tachibana, Yuji Taketani
Publikováno v:
Reproductive Medicine and Biology, Vol 22, Iss 1, Pp n/a-n/a (2023)
Abstract Purpose Vaginal progesterone (VP) alone has been used as luteal support (LS) in HRT‐FET cycles without measuring serum progesterone concentrations (SPC) because it can achieve adequate intrauterine progesterone levels. However, several rep
Externí odkaz:
https://doaj.org/article/6b2f0e0a21cd4f06940505679b7de5c6
Autor:
Michiko Hamada, Michiharu Horikawa, Chie Ensaka, Megumi Enomoto, Rena Ishii, Rena Toriumi, Naoyuki Tachibana, Yuji Taketani
Publikováno v:
Reproductive Medicine and Biology, Vol 21, Iss 1, Pp n/a-n/a (2022)
Abstract Purpose To evaluate the efficacy of an oral gonadotropin‐releasing hormone antagonist (GnRH Ant), relugolix (R), for assisted reproductive technology (ART). Methods We enrolled women undergoing ART using a GnRH Ant for controlled ovarian s
Externí odkaz:
https://doaj.org/article/c0a5fdfed8b94b9eb7fd5ca1a744e404
Autor:
Rena Ishii, Naoyuki Tachibana, Riho Okawa, Megumi Enomoto, Mai Asami, Rena Toriumi, Michiko Hamada, Michiharu Horikawa, Yoko Akiba, Yuji Taketani
Publikováno v:
Reproductive Medicine and Biology, Vol 18, Iss 3, Pp 263-272 (2019)
Abstract Purpose We asked whether the relationship between anti‐Műllerian hormone (AMH) value and the response to ovarian stimulation (OS) might be AMH value‐related and differ for each regimen, aiming at getting clues as to how to choose OS pro
Externí odkaz:
https://doaj.org/article/d9bd00b0979b46d9821be4febf21bca4
Autor:
Rena Ishii, Akiko Shoda, Michiyo Kubo, Satiko Okazaki, Minori Suzuki, Riho Okawa, Megumi Enomoto, Manami Shitanaka, Yoko Fujita, Kazuki Nakao, Nobutaka Shimada, Michiharu Horikawa, Hiroaki Negishi, Yuji Taketani
Publikováno v:
Reproductive Medicine and Biology, Vol 17, Iss 3, Pp 307-314 (2018)
Abstract Purpose To determine whether the cycle regimens that are used for endometrial preparation are associated with the birthweight (BW) after assisted reproductive technology (ART) using frozen‐thawed embryo transfer (FET). Methods The BW of si
Externí odkaz:
https://doaj.org/article/2bf16f4d627649038b9444582390ee42
Autor:
Frank McCormick, Kevan M. Shokat, Zachary A. Knight, Hiroyuki Kuramoto, Yuji Taketani, Keiko Shoji, David Stokoe, Pablo Rodriguez-Viciana, Luika Timmerman, Jennifer Okada, Katsutoshi Oda
Supplementary Figure 5 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2028948d58ff73a23ca5999ebcd82ac3
https://doi.org/10.1158/0008-5472.22375548.v1
https://doi.org/10.1158/0008-5472.22375548.v1
The phosphatidylinositol 3′-kinase (PI3K) pathway is activated in many human cancers. In addition to inactivation of the PTEN tumor suppressor gene, mutations or amplifications of the catalytic subunit α of PI3K (PIK3CA) have been reported. Howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a62c621897de0efad8b972baff3e7a93
https://doi.org/10.1158/0008-5472.c.6494460
https://doi.org/10.1158/0008-5472.c.6494460
Autor:
Frank McCormick, Kevan M. Shokat, Zachary A. Knight, Hiroyuki Kuramoto, Yuji Taketani, Keiko Shoji, David Stokoe, Pablo Rodriguez-Viciana, Luika Timmerman, Jennifer Okada, Katsutoshi Oda
Supplementary Figure 1 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::479145e5454e5b5d97d0a50ee7726797
https://doi.org/10.1158/0008-5472.22375560
https://doi.org/10.1158/0008-5472.22375560
Autor:
Frank McCormick, Kevan M. Shokat, Zachary A. Knight, Hiroyuki Kuramoto, Yuji Taketani, Keiko Shoji, David Stokoe, Pablo Rodriguez-Viciana, Luika Timmerman, Jennifer Okada, Katsutoshi Oda
Supplementary Figure 3 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b05aeda5a908824dfdc5d07f661d2a6
https://doi.org/10.1158/0008-5472.22375554.v1
https://doi.org/10.1158/0008-5472.22375554.v1
Supplementary Data from High Frequency of Coexistent Mutations of PIK3CA and PTEN Genes in Endometrial Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4697f186de5f0d959f7eea67997d0f
https://doi.org/10.1158/0008-5472.22364967.v1
https://doi.org/10.1158/0008-5472.22364967.v1
Autor:
Frank McCormick, Kevan M. Shokat, Zachary A. Knight, Hiroyuki Kuramoto, Yuji Taketani, Keiko Shoji, David Stokoe, Pablo Rodriguez-Viciana, Luika Timmerman, Jennifer Okada, Katsutoshi Oda
Supplementary Tables 1-5 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e27be6b6ee0c987c737644523bdae2b4
https://doi.org/10.1158/0008-5472.22375539.v1
https://doi.org/10.1158/0008-5472.22375539.v1